Skip to main content
. 2013 Sep;1(3):e153–e160. doi: 10.1016/S2214-109X(13)70060-3

Table 2.

Clinical features and initial investigations by virus

Adenovirus (n=42) Cytomegalovirus (n=12) Enterovirus (n=8) Herpes simplex virus 1 (n=8) Human herpes virus 6 (n=16) Mumps virus (n=29) Rabies virus (n=14) Other virus (n=14)* No virus (n=380)
Characteristics
Male sex 22 (52%) 7 (58%) 6 (75%) 7 (88%) 12 (75%) 15 (52%) 11 (79%) 8 (57%) 193 (51%)
Age (months) 15 (6–48) 12 (3–15) 21 (9–26) 27 (16–51) 24 (9–42) 30 (7–78) 84 (72–132) 36 (13–72) 23 (8–48)
Seizures 19 (45%) 5 (42%) 3 (38%) 3 (38%) 9 (56%) 8 (28%) 6 (43%) 10 (71%) 141 (37%)
Unconsciousness 3 (7%) 4 (33%) 1 (13%) 3 (38%) 7 (44%) 8 (28%) 5 (36%) 6 (43%) 84 (22%)
Fever ≥3 days 16 (38%) 1 (8%) 3 (38%) 3 (38%) 6 (38%) 10 (34%) 0 6 (43%) 143 (38%)
Vomiting 3 (7%) 1 (8%) 1 (13%) 4 (50%) 5 (31%) 4 (14%) 0 1 (7%) 51 (13%)
Diarrhoea 4 (10%) 2 (17%) 1 (13%) 0 2 (13%) 1 (3%) 0 1 (7%) 29 (8%)
Runny nose 6 (14%) 2 (17%) 2 (25%) 1 (13%) 3 (19%) 1 (3%) 0 2 (14%) 24 (6%)
Headache 2 (5%) 0 1 (13%) 3 (38%) 2 (13%) 2 (7%) 0 0 26 (7%)
Examination
Temperature ≥39°C 3 (7%) 1 (8%) 0 0 1 (6%) 1 (3%) 2 (14%) 1 (7%) 39 (10%)
Deep coma 12 (29%) 6 (50%) 1 (13%) 3 (38%) 7 (44%) 9 (31%) 4 (29%) 5 (36%) 101 (27%)
Bulging fontanelle 1 (2%) 2 (17%) 0 1 (13%) 3 (19%) 0 0 0 5 (1%)
Neck stiffness 2 (5%) 4 (33%) 0 0 1 (6%) 1 (3%) 4 (29%) 1 (7%) 26 (7%)
Abnormal chest 6 (14%) 2 (17%) 1 (13%) 1 (13%) 2 (13%) 0 0 2 (14%) 12 (3%)
Hepatomegaly 4 (10%) 1 (8%) 2 (25%) 3 (38%) 3 (19%) 2 (7%) 0 1 (7%) 39 (10%)
Splenomegaly 3 (7%) 0 1 (13%) 3 (38%) 2 (13%) 3 (10%) 0 1 (7%) 41 (11%)
Hepatosplenomegaly 3 (7%) 0 1 (13%) 2 (25%) 2 (13%) 1 (3%) 0 1 (7%) 27 (7%)
Flexor posturing 0 1 (8%) 0 0 2 (13%) 2 (7%) 0 0 4 (1%)
Extensor posturing 0 0 0 0 1 (6%) 1 (3%) 0 0 4 (1%)
Opisthotonus 1 (2%) 1 (8%) 0 0 0 0 0 0 10 (3%)
Observed seizure 5 (12%) 0 0 0 2 (13%) 0 1 (7%) 1 (7%) 12 (3%)
Investigations
CSF opening pressure ≥230 cm 0 1 (8%) 0 0 1 (6%) 0 2 (14%) 0 4 (1%)
CSF white cell count >5 per μL 11 (26%) 1 (8%) 4 (50%) 2 (25%) 0 11 (38%) 2 (14%) 8 (57%) 149 (39%)
HIV status
Positive 0 2 (17%) 1 (13%) 0 2 (13%) 2 (7%) 0 2 (14%) 40 (11%)
Negative 11 (26%) 1 (8%) 1 (13%) 0 7 (44%) 7 (24%) 0 3 (21%) 61 (16%)
Not known 29 (69%) 6 (50%) 5 (63%) 0 6 (38%) 19 (66%) 14 (100%) 10 (71%) 284 (75%)
Malaria parasitaemia and CNS virus 11 (26%) 3 (25%) 0 2 (25%) 5 (31%) 7 (24%) 5 (36%) 8 (57%) ..
CNS virus but no malaria parasitaemia 26 (62%) 5 (42%) 5 (63%) 5 (63%) 7 (44%) 19 (66%) 9 (64%) 6 (43%) ..
Outcome
Sequelae 4 (10%) 2 (17%) 2 (25%) 0 2 (13%) 3 (10%) 0 2 (14%) 39 (10%)
Died 11 (26%) 10 (83%) 3 (38%) 1 (13%) 1 (6%) 5 (17%) 14 (100%) 3 (21%) 46 (12%)

Data are n (%) or median (IQR). 11 patients (not shown here) had dual virus infections; each patient had a different combination of viruses: adenovirus in five cases, human herpes virus in four, cytomegalovirus in four, enterovirus in three, mumps in three, herpes simplex virus in one, measles in one, and parvovirus in one. Genotyping indicated that seven of the adenoviruses detected were members of subgroup B, one was subgroup C. Median age of patients with dual infection was 18 months (IQR 15–26), and Blantyre coma score on admission 3 (2–5). Seven patients with dual infection had malaria parasitaemia, three were HIV positive (of five tested), and three had a CSF pleocytosis.·Six children (55%) with dual viral infections died. CSF=cerebrospinal fluid.

*

Epstein-Barr virus (five patients), parvovirus (five), human herpes virus 7 (two), measles (one), JC/BK virus (one).